Luteolin mitigates potassium dichromate-induced nephrotoxicity, cardiotoxicity and genotoxicity through modulation of Kim-1/Nrf2 signaling pathways
Related Experiment Video
Updated: Oct 28, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
Omolola Victoria Awoyomi1, Yemisi Dorcas Adeoye1, Ademola Adetokunbo Oyagbemi2
1Federal College of Animal Health and Production Technology, Ibadan, Nigeria.
Abstract:
Environmental and occupational exposure to chromium compounds has become potential aetiologic agent for kidney disease with excessive generation of free radicals, apoptosis, and inflammatory. These pathophysiologic mechanisms of potassium dichromate (K2 Cr2 O7 ) have been well correlated with nephrotoxicity and cardiotoxicity. The cardioprotective and nephroprotective effects of Luteolin, a known potent antioxidant were evaluated in this study with 40 healthy rats in four experimental groups: Group A (normal saline), Groups B (30 mg/kg K2 Cr2 O7 ), Group C (Luteolin 100 mg/kg and K2 Cr2 O7 30 mg/kg), and Group D (Luteolin 200 mg/kg and K2 Cr2 O7 30 mg/kg), respectively. Markers of antioxidant defense system, oxidative stress, blood pressure and micronucleated polychromatic erythrocytes (MnPEs), immunohistochemistry of Kidney, injury molecule (Kim-1), nuclear factor erythroid 2-related factor 2 (Nrf2), and cardiac troponin I were determined. Administration of K2 Cr2 O7 increased blood pressure parameters in systolic, diastolic and mean arterial blood pressures, markers of oxidative stress, and frequency of micronucleated polychromatic erythrocytes, together with reduction in serum nitric oxide level. Renal Kim-1 and cardiac troponin I expressions were higher, but lower expressions of renal and cardiac Nrf2 were recorded with immunohistochemical analysis. Pre-treatment with Luteolin restored blood pressure parameters, with concomitant reduction in oxidative stress indicators, augmented antioxidant mechanisms and serum Nitric oxide level, lowered the expressions of Kim-1, cardiac troponin I and up-regulated of both cardiac and renal Nrf2, reduced the frequency of micronucleated polychromatic erythrocytes. Taken together, this study therefore demonstrates the cardioprotective, nephro protective and antigenotoxic effects of Luteolin through antioxidantive and radical scavenging mechanisms.
Insights
Luteolin, a potent antioxidant, demonstrated significant cardioprotective, nephroprotective, and antigenotoxic effects against potassium dichromate (K2Cr2O7) induced toxicity in rats by mitigating oxidative stress and inflammation.
Area of Science:
- Toxicology
- Pharmacology
- Biochemistry
Background:
- Environmental and occupational exposure to chromium compounds like potassium dichromate (K2Cr2O7) is linked to kidney disease due to oxidative stress, apoptosis, and inflammation.
- These mechanisms contribute to nephrotoxicity and cardiotoxicity, highlighting the need for protective agents.
Purpose of the Study:
- To evaluate the cardioprotective and nephroprotective effects of Luteolin, a natural antioxidant, against K2Cr2O7-induced toxicity in a rat model.
- To investigate the impact of Luteolin on oxidative stress markers, blood pressure, and specific molecular indicators of kidney and cardiac injury.
Main Methods:
- Forty healthy rats were divided into four groups: control, K2Cr2O7 exposure, and two groups pre-treated with different doses of Luteolin before K2Cr2O7 exposure.
- Key parameters assessed included blood pressure, oxidative stress markers, nitric oxide levels, micronucleated polychromatic erythrocytes (MnPEs), and immunohistochemical analysis for kidney injury molecule (Kim-1), Nrf2, and cardiac troponin I.
Main Results:
- Potassium dichromate (K2Cr2O7) administration elevated blood pressure, oxidative stress, and MnPEs frequency, while decreasing nitric oxide levels.
- K2Cr2O7 exposure increased renal Kim-1 and cardiac troponin I expression, alongside decreased Nrf2 expression in both organs.
- Luteolin pre-treatment normalized blood pressure, reduced oxidative stress, enhanced antioxidant capacity and nitric oxide levels, downregulated Kim-1 and cardiac troponin I, and upregulated Nrf2, while decreasing MnPEs frequency.
Conclusions:
- Luteolin exhibits significant cardioprotective, nephroprotective, and antigenotoxic effects.
- These protective actions are mediated through Luteolin's potent antioxidant and radical scavenging properties.
- Luteolin represents a promising therapeutic agent for mitigating chromium-induced organ damage.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Diuretics
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

